Sjoerd Rodenhuis - NKI / AvL
Sjoerd Rodenhuis - NKI / AvL
Sjoerd Rodenhuis - NKI / AvL
SHOW LESS
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
The validation of 2 Discoveries<br />
1. Should intensive chemotherapy with<br />
bifunctional alkylators be employed for tumors<br />
enriched for a homologous recombination<br />
defect (BRCA‐like aCGH) ?<br />
2. Paired CE‐MRI is very good in predicting pCR in<br />
TN disease. Should ddAC continue in the<br />
presence of a favorable MRI‐response or should<br />
every patient have the benefit of a taxane?
Change language